The mammography detectors market is projected to expand from US$ 155.69 million in 2022 to US$ 234.65 million by 2030, reflecting a compound annual growth rate (CAGR) of 5.3% from 2022 to 2030.

The anticipated growth in the mammography detectors sector is primarily driven by the rising prevalence of breast cancer and an increasing awareness of the critical role that early detection plays in successful treatment. Nevertheless, the high costs associated with mammography procedures pose a significant challenge to market expansion.

In terms of market share, North America leads, followed closely by Europe. The growth observed in Europe can be linked to the rising rates of breast cancer, the presence of key industry players, and vigorous research and development initiatives. In Germany, breast cancer is the most frequently diagnosed cancer among women. According to Globocan 2020, approximately 69,697 new breast cancer cases were reported in Germany in 2020, accounting for 11.1% of all cancer diagnoses. This disease resulted in 20,579 deaths, with a five-year prevalence rate of 707.38 per 100,000 individuals across all age groups. The annual cost of breast cancer treatment in Germany is estimated at around US$ 2.13 billion (2 billion euros). The German Cancer Society indicates that one in eight women will be diagnosed with breast cancer in their lifetime. A study by the Bundesamt f?r Strahlenschutz highlights that despite advancements in treatment, around 70,000 new cases are diagnosed each year, with approximately 17,000 women dying from the disease annually.

In Great Britain, the National Health Service (NHS) reports that about one in seven women will receive a breast cancer diagnosis during their lifetime, with around 55,000 new cases identified each year. In January 2023, the UK government announced an investment of an additional US$ 12.31 million (?10 million) to establish 29 new NHS breast cancer screening units and upgrade nearly 70 existing services in areas with the greatest need. This funding aims to enhance accessibility to NHS services, allowing patients to receive care closer to home.

Various organizations are implementing programs to facilitate breast cancer screenings, which can lead to improved treatment outcomes. For example, Radiologie am Theater in Paderborn, Germany, operates three specialized breast cancer diagnostic centers. The facility reports conducting over 15,000 breast examinations annually. Additionally, women aged 50 to 69 in Germany are eligible for a complimentary mammogram every two years, which aids in the early detection of breast cancer, thereby improving treatment options and recovery rates. These initiatives contribute positively to the growth of the market in the region during the forecast period.

**Detector Type -Based Insights**

The mammography detectors market is categorized by detector type into computed radiography detectors, flat panel detectors, CMOS flat detectors, and others. In 2022, the flat panel detectors segment dominated the market. However, the CMOS flat detectors segment is expected to experience the highest CAGR from 2022 to 2030.

Computed radiography (CR) is a widely used technique for generating digital radiographic images. This technology employs a cassette-based system to capture and process X-ray images, serving as an alternative to both direct digital mammography and traditional analog film-screen mammography. The CR system consists of a cassette containing an imaging plate (phosphor plate) that is exposed to X-ray radiation instead of film. The phosphor plate is composed of materials that can store X-ray energy as electrons when exposed. During a mammography procedure, the breast is placed on the cassette, allowing X-ray photons to penetrate the tissue and strike the phosphor plate. The cassette is then inserted into a CR reader or scanner, which utilizes a laser beam to scan the phosphor plate, releasing the trapped electrons as light. This emitted light is captured by light-sensitive detectors within the CR reader, which convert it into electrical signals that are processed and digitized by a computer. The resulting digital image is displayed on a monitor for evaluation using specialized software. The processing aims to enhance image quality by minimizing noise, eliminating artifacts, and improving contrast as needed. Ultimately, the processed digital image is utilized by radiologists for analysis and interpretation of the mammogram.

The CR system is often regarded as a cost-effective initial option. Carestream provides a CR mammography solution featuring the DIRECTVIEW Classic CR System and DirectView software, along with various printing options. The Classic CR's mammography-specific image plates and cassettes are compatible with existing mammography systems. Due to its versatility in both digital mammography and general radiography, this CR system can be applied across multiple settings. Furthermore, its robust design ensures reliability and durability, reducing wear and tear. The Classic CR system also facilitates quicker and more accurate diagnoses.

CR technology is particularly economical as it allows facilities to transition from analog film-screen mammography to digital imaging without the need for complete equipment replacement. It significantly enhances image quality, leading to improved operational efficiencies and consistently high-quality outputs. Overall, the adoption of CR detectors in mammography enhances efficiency, flexibility, and accessibility, resulting in more precise and timely breast cancer detection and diagnosis.

The World Health Organization (WHO) and Globocan serve as the primary and secondary sources referenced in the preparation of the mammography detectors market report.